Royal Bank Of Canada Pfizer Inc Call Options Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $9.98 Million - $11.7 Million	395,200 Added 103.35%	777,600 $21.8 Million
Q1 2024 Nov 05, 2024	SELL	$25.89 - $29.73 $10.2 Million - $11.7 Million	-395,200 Reduced 50.82%	382,400 $10.6 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $7.32 Million - $8.41 Million	282,900 Added 284.32%	382,400 $10.6 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.82 Million - $2.36 Million	69,500 Added 231.67%	99,500 $2.86 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.46 Million - $1.7 Million	-45,400 Reduced 60.21%	30,000 $995,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.35 Million - $2.72 Million	65,100 Added 632.04%	75,400 $2.77 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $6.29 Million - $8.19 Million	-159,800 Reduced 93.94%	10,300 $420,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $2.15 Million - $2.81 Million	-51,500 Reduced 23.24%	170,100 $8.72 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $2.25 Million - $2.75 Million	51,500 Added 30.28%	221,600 $9.7 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $6.14 Million - $7.61 Million	134,200 Added 373.82%	170,100 $8.81 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $4.55 Million - $6.74 Million	-110,100 Reduced 75.41%	35,900 $2.12 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $4.32 Million - $5.55 Million	110,100 Added 306.69%	146,000 $6.28 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $1.29 Million - $1.46 Million	35,900 New	35,900 $1.41 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.